Paranovus Entertainment Technology Ltd.
NASDAQ:PAVSMedical - Pharmaceuticals
+$1.28 today
- Market cap
- $353.07M
- Beta
- -0.35
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$9.07
Volume 0.16M
Average 113.44M
PAVS Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Paranovus Entertainment Technology Ltd.NASDAQ: PAVS
Free Cash Flow · Q2 FY2025 · quarter ended Sep 2025
Free cash flow declines year over year
Q2 FY2025 free cash flow of $159.34K (cash outflow) fell 83.5% year over year. Over 3 fiscal years it compounded at -55.6% a year.
Context
- Free cash flow amounted to 3731.3% of revenue in FY2024.
- Free cash flow grew in size in 1 of the last 3 fiscal years.
- FY2024 was the smallest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2024
- (2.67M) USD
- Year-over-year change
- +79.6%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | (2.67M) | +79.6% |
| FY2023 | 2024-03-31 | (13.11M) | -341.7% |
| FY2022 | 2023-03-31 | (2.97M) | +90.3% |
| FY2021 | 2022-03-31 | (30.53M) | -25321.1% |
| FY2020 | 2021-03-31 | 121.03K | — |
Free Cash Flow vs competitors
How PAVS compares with its peers on the latest reported figures
- PAVS's FY2024 free cash flow of $2.67M is the smallest of the 4 companies compared; the peer median is $8.05M.
- Its year-over-year change of -79.6% is the lowest of 4, against a peer median of +40.1%.
- Free cash flow amounts to 3731.3% of revenue for PAVS, versus a peer median of 13.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
WYHGWing Yip Food Holdings Group Limited American Depositary Shares | LTM Mar 2026 | $17.64M | +40.1% | +1158.9% | 13.3% |
| LTM Mar 2026 | $8.05M | -14.9% | +45.5% | 61.3% | |
| LTM Mar 2026 | $5.43M | +6367.3% | -43.0% | 12.8% | |
| FY2024 | $2.67M | -79.6% | -55.6% | 3731.3% | |
| Peer median (excluding PAVS) | $8.05M | +40.1% | +45.5% | 13.3% | |
Competitors are the stored peer set for PAVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Mar 2021 | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|---|
| Net Income | 786.36K | (49.19M) | (4.08M) | (4.49M) | (6.59M) |
| Depreciation & Amortization | 880.88K | 2.19M | 58.75K | 380K | 380K |
| Deferred Income Tax | 0 | (3.92M) | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 553.21K | 15.13M | (472.7K) | (1.06M) | 100.12K |
| Accounts Receivables | (2.11M) | 23.13M | 13.52K | (11.36K) | 0 |
| Inventory | 389.39K | 454.26K | 344.48K | 0 | 0 |
| Accounts Payables | 6.72M | (4.85M) | 1.31M | 0 | 0 |
| Other Working Capital | (4.45M) | (3.61M) | (2.14M) | (1.05M) | 100.12K |
| Other Non-Cash Items | 684.02K | 7.66M | 1.53M | (7.94M) | 3.44M |
| Operating Cash Flow | 2.9M | (28.13M) | (2.97M) | (13.11M) | (2.67M) |
| Capital Expenditures | (2.78M) | (2.39M) | 0 | 0 | (4) |
| Acquisitions (Net) | (9.35M) | (8M) | 0 | 0 | (22.29M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | (4.76M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 1.93M | 89.32K | 11.7M | 0 |
| Investing Cash Flow | (13.19M) | (8.48M) | 89.32K | 11.7M | (27.05M) |
| Debt Repayment | 44.14K | (46.81K) | 0 | 0 | 158.09K |
| Common Stock Issued | 10.97M | 18.88M | 3M | 0 | 27M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (375K) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 145.52K | 0 | 1.85M |
| Financing Cash Flow | 10.63M | 18.83M | 3.15M | 0 | 29.01M |
| Effect of Forex Changes | 2.55M | 955.76K | (17.95M) | (299.98K) | 629.12K |
| Net Change in Cash | 2.9M | (16.83M) | (17.68M) | (1.71M) | (80.42K) |
| Free Cash Flow | 121.03K | (30.53M) | (2.97M) | (13.11M) | (2.67M) |
Paranovus Entertainment Technology Ltd.
NASDAQ:PAVS
Intrinsic Alpha fair value
Locked
Current Price
$7.02
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.